Uncommon EGFR Exon 19 Mutations Confer Gefitinib Resistance in Advanced Lung Adenocarcinoma
- PMID: 26001153
- DOI: 10.1097/JTO.0000000000000538
Uncommon EGFR Exon 19 Mutations Confer Gefitinib Resistance in Advanced Lung Adenocarcinoma
Comment on
-
A novel EGFR mutation in exon 19 showed stable disease after TKI treatment.J Thorac Oncol. 2012 Aug;7(8):e8. doi: 10.1097/JTO.0b013e31825ccae8. J Thorac Oncol. 2012. PMID: 22797155 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
